You can buy or sell Syros and other stocks, options, ETFs, and crypto commission-free!
Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425 and SY-5609. Read More The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.
52 Week High
52 Week Low
— per share
Expected Aug 6, Pre-Market